MRDeep study: measurable residual disease rates in patients with multiple myeloma who achieved complete response in 2nd or 3rd lines of treatment

M Neves, R Gerivaz, G Esteves, R Bergatim, G Ferreira, H Coelho, C Afonso, D Duarte, A Neves, HM Silva, J Caetano, R Jaime, C Geraldes, P Lúcio

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S77-S78
Number of pages2
JournalClinical Lymphoma, Myeloma and Leukemia
Publication statusPublished - Sept 2023

Cite this